This is a demo store. No orders will be fulfilled.

Vipivotide tetraxetan (PSMA-617) - 98%, high purity , CAS No.1702967-37-0, Inhibitor of Folate hydrolase (prostate-specific membrane antigen) 1

In stock
Item Number
V414106
Grouped product items
SKU Size
Availability
Price Qty
V414106-1mg
1mg
3
$207.90
V414106-2mg
2mg
3
$345.90
V414106-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$761.90
V414106-10mg
10mg
3
$1,236.90
V414106-25mg
25mg
2
$2,523.90
V414106-50mg
50mg
2
$4,305.90

Drug-Linker Conjugates for ADC

Basic Description

Synonyms 1702967-37-0 | Vipivotide tetraxetan | s8670 | PSMA617 | PSMA-617 | Sodium phosphate monobasic monohydrate, BioXtra, for molecular biology, >=99.5% (T) | NACLO3 | -LYSINE, N2-((((1S)-1,3-DICARBOXYPROPYL)AMINO)CARBONYL)-N6-(3-(2-NAPHTHALENYL)-N-((TRANS-4-(
Specifications & Purity Moligand™, ≥98%
Biochemical and Physiological Mechanisms Vipivotide tetraxetan (PSMA-617) is a chemically modified PSMA(prostate-specific membrane antigen) inhibitor with a Ki of 0.37 nM.
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type INHIBITOR
Mechanism of action Inhibitor of Folate hydrolase (prostate-specific membrane antigen) 1
Product Description

Information

Vipivotide tetraxetan (PSMA-617) is a chemically modified PSMA(prostate-specific membrane antigen) inhibitor with a Ki of 0.37 nM.


Targets

PSMA (Cell-free assay) 0.37 nM(Ki)


In vitro

PSMA-617 demonstrates high radiolytic stability for at least 72 h. A high inhibition potency (equilibrium dissociation constant Ki = 2.34 ± 2.94 nM on LNCaP; Ki = 0.37 ± 0.21 nM enzymatically determined) and highly efficient internalization into LNCaP cells are demonstrated.


In vivo

The small-animal PET measurements show high tumor-to-background contrasts as early as 1 h after injection. In vivo distribution reveals specific uptake in LNCaP tumors and in the kidneys 1 h after injection. With regard to therapeutic use, PSMA-617 exhibits a rapid clearance from the kidneys from 113.3 ± 24.4 at 1 h to 2.13 ± 1.36 percentage injected dose per gram at 24 h. The favorable pharmacokinetics of the molecule leads to tumor-to-background ratios of 1,058 (tumor to blood) and 529 (tumor to muscle), respectively,24 h after injection.


Cell Research(from reference)

Cell lines:PSMA-positive LNCaP cell line 

Concentrations:0–5000 nM 

Incubation Time:1 h 

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organic acids and derivatives
Class Carboxylic acids and derivatives
Subclass Hexacarboxylic acids and derivatives
Intermediate Tree Nodes Not available
Direct Parent Hexacarboxylic acids and derivatives
Alternative Parents Glutamic acid and derivatives  N-carbamoyl-alpha amino acids  N-acyl-alpha amino acids and derivatives  Alpha amino acid amides  Naphthalenes  Alpha amino acids  N-acyl amines  Trialkylamines  Organic carbonic acids and derivatives  Amino acids  Carboxylic acids  Carboxylic acid amides  Azacyclic compounds  Organopnictogen compounds  Organooxygen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Hexacarboxylic acid or derivatives - Glutamic acid or derivatives - N-carbamoyl-alpha-amino acid or derivatives - N-carbamoyl-alpha-amino acid - N-acyl-alpha amino acid or derivatives - Alpha-amino acid amide - Naphthalene - Alpha-amino acid or derivatives - N-substituted-alpha-amino acid - Alpha-amino acid - Fatty acyl - Benzenoid - N-acyl-amine - Fatty amide - Amino acid - Tertiary aliphatic amine - Tertiary amine - Carbonic acid derivative - Carboxamide group - Amino acid or derivatives - Azacycle - Organoheterocyclic compound - Carboxylic acid - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Amine - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as hexacarboxylic acids and derivatives. These are carboxylic acids containing exactly six carboxyl groups.
External Descriptors Not available

Product Properties

ALogP -11.549
HBD Count 5
Rotatable Bond 27

Associated Targets(Human)

FOLH1 Tclin Glutamate carboxypeptidase 2 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
FOLH1 Tclin Glutamate carboxypeptidase II (711 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

Pubchem Sid 504772988
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504772988
IUPAC Name (2S)-2-[[(1S)-1-carboxy-5-[[(2S)-3-naphthalen-2-yl-2-[[4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]cyclohexanecarbonyl]amino]propanoyl]amino]pentyl]carbamoylamino]pentanedioic acid
INCHI InChI=1S/C49H71N9O16/c59-40(28-55-17-19-56(29-42(62)63)21-23-58(31-44(66)67)24-22-57(20-18-55)30-43(64)65)51-27-32-8-12-35(13-9-32)45(68)52-39(26-33-10-11-34-5-1-2-6-36(34)25-33)46(69)50-16-4-3-7-37(47(70)71)53-49(74)54-38(48(72)73)14-15-41(60)61/h1-2,5-6,10-11,25,32,35,37-39H,3-4,7-9,12-24,26-31H2,(H,50,69)(H,51,59)(H,52,68)(H,60,61)(H,62,63)(H,64,65)(H,66,67)(H,70,71)(H,72,73)(H2,53,54,74)/t32?,35?,37-,38-,39-/m0/s1
InChIKey JBHPLHATEXGMQR-VLOIPPKDSA-N
Smiles C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O
Isomeric SMILES C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O
PubChem CID 122706786
Molecular Weight 1042.14

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot Number Certificate Type Date Item
K2216518 Certificate of Analysis Aug 16, 2022 V414106
K2216501 Certificate of Analysis Aug 16, 2022 V414106
B23081168 Certificate of Analysis Aug 16, 2022 V414106
K2216497 Certificate of Analysis Aug 16, 2022 V414106
K2216517 Certificate of Analysis Aug 16, 2022 V414106

Chemical and Physical Properties

Solubility Solubility (25°C) In vitro Water: 100 mg/mL (95.95 mM);    
DMSO(mg / mL) Max Solubility -1
DMSO(mM) Max Solubility -0.959563974130155
Water(mg / mL) Max Solubility 100
Water(mM) Max Solubility 95.9563974130155
Molecular Weight 1042.099 g/mol
XLogP3 -8.200
Hydrogen Bond Donor Count 11
Hydrogen Bond Acceptor Count 20
Rotatable Bond Count 27
Exact Mass 1041.5 Da
Monoisotopic Mass 1041.5 Da
Topological Polar Surface Area 365.000 Ų
Heavy Atom Count 74
Formal Charge 0
Complexity 1870.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 3
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.